HERTS, United Kingdom, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Zhuding International Limited (OTC: ZHUD), a Nevada corporation, and Automated Water Solutions Inc., (AWS), a Texas corporation, are pleased to announce the signing of a Reverse Merger Agreement for the acquisition of AWS by ZHUD that will result in AWS having control over ZHUD. The effective date of the merger is 10/31/24.

CAMBRIDGE, Mass., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced positive new clinical data from the ongoing Phase 1 trial of nexiguran ziclumeran (nex-z, also known as NTLA-2001) in patients with transthyretin (ATTR) amyloidosis. Nex-z is an investigational in vivo CRISPR-based gene editing therapy in development as a one-time treatment for ATTR amyloidosis. Development and commercialization of nex-z is led by Intellia as part of a multi-target collaboration with Regeneron.

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from post-hoc analyses of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 cardiovascular outcomes clinical trial of omecamtiv mecarbil were presented at the American Heart Association Scientific Sessions 2024 in Chicago, IL.

Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life

SHENZHEN, China, Nov. 16, 2024 (GLOBE NEWSWIRE) -- BYD Co. Ltd., expands the partner program for BYD Energy Storage solutions. As part of the program, BYD held a partner conference at the BYD headquarters in November 2024, in which partners had the opportunity to voice their experiences, have an exchange with the technical team and receive an exclusive preview on upcoming new products and features.

SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved toripalimab (UK trade name: LOQTORZI®) for the treatment of two indications:

The Prospectus Supplement and Base Shelf Prospectus are accessible through SEDAR+

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

GUANGZHOU, China, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), today announced that it has filed its annual report for the fiscal year ended June 30, 2024 on Form 20-F (the “FY2024 20-F”), which contains its audited financial statements for the fiscal year ended June 30, 2024, with the U.S. Securities and Exchange Commission (the “SEC”) on November 15, 2024. The FY2024 20-F can be accessed on the SEC’s website at http://www.sec.gov as well as on the Investor Relations page of the Company’s website at https://ir.puyiwm.com/financial-information/sec-filings. Hard copies of the annual report are available, free of charge, to its shareholders upon request.

VANCOUVER, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) ("Teck”) has been named one of Canada’s Top 100 Employers for the eighth consecutive year by Mediacorp Canada’s Top Employers program, which recognizes companies for exceptional human resource programs and innovative workplace policies.

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company received formal notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s failure to timely file the Form 20-F for the fiscal year ended December 31, 2023 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company no longer satisfied Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”) and its securities are therefore subject to suspension and delisting unless the Company timely requests a hearing before and a further stay of any suspension action at least pending the ultimate conclusion of the hearings process from the Nasdaq Hearings Panel (the “Panel”).

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that data from an interim analysis of the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC) will be featured during a poster session at the upcoming 25^th Annual Meeting of the Society of Urologic Oncology (SUO) taking place December 4, 2024 to December 6, 2024, in Dallas, Texas. The presentation will include safety data featured in the abstract published today on the SUO website, as well as updated safety and new efficacy data from approximately 20 enrolled patients, the majority of whom are six-month evaluable.

SURREY, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), TSX.V: AMY, OTCQB: AMYZF, FSE: ID4, a pioneer in sustainable lithium-ion battery recycling technology, is pleased to announce that its annual general meeting (the “AGM”) will be held on Thursday, December 12, 2024, at 1:00 p.m. (Vancouver time) at the Executive Hotel Vancouver Airport, Executive Board Room, 7311 Westminster Hwy, Richmond, BC, V6X 1A3.

HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.51 per share, payable on Jan. 24, 2025, to common stockholders of record at the close of business on Jan. 3, 2025.

XI’AN, CHINA, Nov. 15, 2024 (GLOBE NEWSWIRE) -- China Green Agriculture, Inc. (NYSE: CGA) has changed its name to Enlightify Inc., effective November 25, 2024. Its ticker symbol will change to ENFY effective November 25, 2024, and it is expected to begin trading under that symbol on November 26, 2024. The Company mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China.

WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to file its own Form 25 (Notification of Removal of Listing) with the U.S. Securities and Exchange Commission (the “SEC”) to complete the previously-disclosed process to delist the Company’s common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Market in advance of Nasdaq’s anticipated filing of a Form 25 with the SEC.

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “Company” or “Halcones”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Halcones held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  The appointment of each of the nominees to the Company’s board was approved by more than 99% of the votes cast at the Meeting.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

CALGARY, Alberta, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto") confirms that the monthly dividend with respect to November 2024 of $0.11 per common share is to be paid on December 13, 2024, for shareholders of record on November 30, 2024.

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Nobel Resources Corp. (TSX–V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Nobel held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today its November 2024 monthly distribution in the amount of $0.125 per Unit (or $1.50 on an annualized basis). The November 2024 distribution will be payable on December 16, 2024 to Unitholders of record at the close of business on November 29, 2024.